View in EDS HTML Full Text PDF Full Text

Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer.

Saved in:
Bibliographic Details
Title: Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer.
Authors: Liu F; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Monterosso ME; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Boucher D; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Shakti S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Li KC; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kim C; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Prior A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Sydes A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Soderholm AT; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Fletcher N; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Akhter D; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Thurecht K; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Tieu W; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kuan K; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Horsfall A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kumar S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Koehbach J; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Hammond E; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Karmann A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Rose S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Li G; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au., Puttick S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kryza T; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Nov 03; Vol. 66 (11), pp. 1703-1713. Date of Electronic Publication: 2025 Nov 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40998733
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical Evaluation of [<superscript>212</superscript>Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+F%22">Liu F</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Monterosso+ME%22">Monterosso ME</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Boucher+D%22">Boucher D</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Shakti+S%22">Shakti S</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Li+KC%22">Li KC</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Kim+C%22">Kim C</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Prior+A%22">Prior A</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Sydes+A%22">Sydes A</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Soderholm+AT%22">Soderholm AT</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Fletcher+N%22">Fletcher N</searchLink>; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Akhter+D%22">Akhter D</searchLink>; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Thurecht+K%22">Thurecht K</searchLink>; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Tieu+W%22">Tieu W</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Kuan+K%22">Kuan K</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Horsfall+A%22">Horsfall A</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Koehbach+J%22">Koehbach J</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Hammond+E%22">Hammond E</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Karmann+A%22">Karmann A</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Rose+S%22">Rose S</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Li+G%22">Li G</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au.<br /><searchLink fieldCode="AU" term="%22Puttick+S%22">Puttick S</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and.<br /><searchLink fieldCode="AU" term="%22Kryza+T%22">Kryza T</searchLink>; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2025 Nov 03; Vol. 66 (11), pp. 1703-1713. <i>Date of Electronic Publication: </i>2025 Nov 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40998733
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.269707
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1703
    Titles:
      – TitleFull: Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu F
      – PersonEntity:
          Name:
            NameFull: Monterosso ME
      – PersonEntity:
          Name:
            NameFull: Boucher D
      – PersonEntity:
          Name:
            NameFull: Shakti S
      – PersonEntity:
          Name:
            NameFull: Li KC
      – PersonEntity:
          Name:
            NameFull: Kim C
      – PersonEntity:
          Name:
            NameFull: Prior A
      – PersonEntity:
          Name:
            NameFull: Sydes A
      – PersonEntity:
          Name:
            NameFull: Soderholm AT
      – PersonEntity:
          Name:
            NameFull: Fletcher N
      – PersonEntity:
          Name:
            NameFull: Akhter D
      – PersonEntity:
          Name:
            NameFull: Thurecht K
      – PersonEntity:
          Name:
            NameFull: Tieu W
      – PersonEntity:
          Name:
            NameFull: Kuan K
      – PersonEntity:
          Name:
            NameFull: Horsfall A
      – PersonEntity:
          Name:
            NameFull: Kumar S
      – PersonEntity:
          Name:
            NameFull: Koehbach J
      – PersonEntity:
          Name:
            NameFull: Hammond E
      – PersonEntity:
          Name:
            NameFull: Karmann A
      – PersonEntity:
          Name:
            NameFull: Rose S
      – PersonEntity:
          Name:
            NameFull: Li G
      – PersonEntity:
          Name:
            NameFull: Puttick S
      – PersonEntity:
          Name:
            NameFull: Kryza T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2025 Nov 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1